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Abstract: Up to 436,000 adult Danes suffer from chronic obstructive pulmonary disease 
(COPD), with only one third diagnosed at this time. The Danish National Board of Health 
recommends early detection of COPD, focusing on smokers/ex-smokers over 35 years of age 
with at least one lung symptom. A governmental prevention committee has suggested that the 
municipalities, in addition to general practice, should be a potential arena responsible for early 
detection of COPD. We undertook a pilot study to investigate the feasibility and effectiveness 
of early detection of COPD in municipalities following the recommendations of the Danish 
National Board of Health.
Methods: The Municipality of Esbjerg offered spirometry to Danish citizens at risk of COPD 
without a previous diagnosis of the disease, following the National Board of Health’s recommen-
dations. Citizens with evidence of airway obstruction (forced expiratory volume in one second 
[FEV1]/forced vital capacity [FVC] ,70%) were advised to visit their general practitioner for 
diagnosis. These citizens were followed up by telephone interview 3 months later.
Results: Of 152 citizens sampled (50% females, mean age 58 years, 51% smokers) 51.3% had 
evidence of airway obstruction, with 87% being mild to moderate in terms of severity. Seven 
of ten citizens (71%) then visited their general practitioner, with 85% of these being diagnosed 
with COPD. The number of smokers embarking on smoking cessation or quitting smoking 
increased following COPD screening, with the highest frequency in participants with evidence 
of airway obstruction.
Conclusion: In addition to early detection of COPD in general practice, early detection of 
airway obstruction in defined risk populations in Danish municipalities seems feasible and 
  effective for identifying new patients with COPD. However, additional research is needed in 
larger samples to confirm the results of the present study.
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Background
Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow 
limitation and a range of pathological changes in the lung, significant extrapulmonary 
effects, and important comorbidities.1 A recent study suggests that 300,000–436,000 
Danes (7%–10% of the adult population) suffer from COPD.2 However, only 
  approximately 150,000 of these citizens appear to have been diagnosed at this time.3
A total of 21,386 Danes were hospitalized and 3478 deaths occurred in 2009 as a 
result of COPD.4,5 Illustrating the burden of the disease, in 2002, each COPD patient 
incurred an extra  4400 per year in health care costs compared with patients without 
the disease.6 Health care costs increase with stage of COPD severity.7–9 To reduce 
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costs, loss of quality of life, and premature death, early iden-
tification and diagnosis of COPD would be beneficial.
The risk factors for COPD are well known, with tobacco 
smoking accounting for 80%–90% of cases, and occupa-
tional and environmental risk factors for 10%–20%.1,10–12 
According to current guidelines, management of COPD 
includes assessment and monitoring of the disease, reduc-
tion of risk factors to prevent progression, management of 
stable COPD, and management of exacerbations.1 For newly 
diagnosed and stable COPD patients, this implies initiation 
of smoking cessation for cigarette smokers, physical training, 
pharmacotherapy, patient education, dietary supervision, and 
psychosocial assistance.1,3 Rehabilitation of COPD patients 
takes place in hospitals, general practice, or at the munici-
pality level.13–15 In Denmark, the National Board of Health 
recommends that patients undertake relevant prevention and 
rehabilitation initiatives. These initiatives include smoking 
cessation, preventing progression of loss of lung capacity, 
implementing optimal pharmacological therapy, and early 
detection of COPD, ie, screening.3
The Global Strategy for the Diagnosis, Management, 
and Prevention of COPD (GOLD) concludes that there is 
insufficient evidence at this time to recommend community-
based spirometric screening for COPD.1 Similarly, in 2008, 
the US Preventive Services Task Force advised against use 
of spirometry to screen for COPD in adults who do not 
recognize or report respiratory symptoms to a clinician.16 The 
American College of Physicians also concluded in 2007 that 
spirometry should not be used to screen for airflow obstruc-
tion in asymptomatic individuals, including those with risk 
factors for COPD.17
On the other hand, according to a Cochrane review, 
studies have shown the importance of early diagnosis and 
intervention of COPD to have an adequate effect.18 In a recent 
review of spirometry, Soriano et al stated that screening at 
all levels can be undertaken in community or health care set-
tings, and that spirometry is the essential test for diagnosis 
and monitoring of COPD, although maintaining the quality 
of diagnostic spirometry is essential.19
In Denmark, the National Board of Health recommends 
that early detection of COPD should focus on patients older 
than 35 years and smokers/former smokers with one or more 
respiratory symptoms.3 A spirometric investigation should be 
offered to the population at risk as early as possible. People 
employed in high-risk occupations (eg, welders, bakers, 
dustmen) are also included in the recommendation.
Studies of early detection of COPD have primarily 
been carried out in general practice and hospital settings. 
One example from primary care is a study by Ulrik et al who 
screened 3095 Danish patients using the same definition of 
risk as that used in our present study and identified 34.8% of 
patients with airway obstruction in accordance with GOLD.20 
In another Danish study of walk-in spirometry carried out by 
regional hospitals in one region of Denmark in cooperation 
with The Danish Lung Association, markedly fewer patients 
(20% of 344 screened) were found to have COPD.21 However, 
in that study, spirometry examinations were only offered on 
one afternoon per month and were carried out by hospital 
staff. Internationally, using COPD screening in primary care 
practices in the UK and US, Tinkelman et al found that 18.9% 
of 818 smoking patients over 39 years of age had COPD.22 
Similarly, in a Canadian study by Hill et al of 1459 patients 
in primary care, 20.7% were found to have COPD.23 Finally, 
Zielinski et al found that 24.3% of patients screening at 12 
pulmonary outpatient clinics in Poland had COPD.24
In 2009, a government prevention committee in Denmark 
suggested that the municipalities could be one potential arena 
responsible for early detection of COPD, in addition to general 
practice.25 Adding to the knowledge base, it would therefore 
be of interest to investigate the feasibility and effectiveness 
of early detection of COPD in the municipality setting based 
on the recommendations issued by the Danish National Board 
of Health and the governmental prevention commission. The 
aim of the present study was to investigate the feasibility and 
effectiveness of early detection of airway obstruction and 
COPD at the municipality level in Denmark.
Methods
This pilot study was undertaken at the Healthcare Center 
of the Municipality of Esbjerg, which is the fifth largest 
municipality in Denmark and has approximately 115,000 
inhabitants. The Healthcare Center recruited citizens at risk 
of COPD from local newspaper advertisements, from exist-
ing municipality courses and training, and from screening at 
market places. Recruitment for airway obstruction screen-
ing was based on self-referral. The study was designed and 
conducted as a noninterventional study, thus the screening 
and procedures followed current Danish guidelines. In accor-
dance with the recommendations of the Danish National 
Board of Health, the inclusion criteria were:
•	 Age .35 years
•	 Smoker or ex-smoker
•	 Presence of at least one respiratory symptom, eg, dyspnea, 
cough, wheeze, phlegm
•	 Citizenship in the Municipality of Esbjerg
•	 No previous diagnosis of COPD.3
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Individuals employed in high-risk occupations were not 
part of this screening. From September to December 2009, 
trained municipality health care personnel, ie, nurses and 
physiotherapists with experience in spirometry, offered spiro-
metric investigations to citizens. The spirometry screening 
was done in accordance with American Thoracic Society/
European Respiratory Society guidelines but without bron-
chodilator testing for reversibility.26 The spirometer used 
was the Spirotrac IV (Model 6800, Ireland). Health care 
personnel performing and evaluating the spirometry were 
thoroughly trained, initially by a pulmonary specialist, ie, 
a hospital consultant with extensive experience in COPD 
and spirometry examination. The spirometer was calibrated 
before screening was initiated. Because this study was 
conducted in the community setting, there was no record-
ing of comorbidities at the time of screening. Citizens with 
evidence of airway obstruction were requested to visit their 
general practitioner to undergo repeat spirometry and revers-
ibility testing for further diagnosis and eventual treatment. 
Three months after screening, all citizens were interviewed 
by telephone to confirm whether the general practitioner 
was visited (if requested), the general practitioner’s action 
in terms of diagnosis and treatment, and smoking cessation 
and abstinence. Abstinence from smoking was measured 
using self-assessment and point prevalence, ie, asking the 
citizen whether he/she smokes now as opposed to ongoing 
monitoring for a period of time. To minimize response bias, 
the interview was not carried out by the same person doing the 
spirometry. Seven unanswered telephone calls were deemed 
to be a nonresponse.
Airway obstruction was defined according to GOLD 
guidelines,1 ie, an FEV1 to FVC ratio below 70%, which 
is identical to the current guidelines for primary care in 
Denmark.3,27 The indication of severity of a possible diagnosis 
of COPD was reported using FEV1 in relation to the expected 
level from normative Danish lung function data. Staging 
based on screening spirometry was as follows:
•	 Mild COPD, FEV1 $ 80% of expected
•	 Moderate COPD, 50% # FEV1 , 80% of expected
•	 Severe COPD, 30% # FEV1 , 50% of expected
•	 Very severe COPD, FEV1 , 30% of expected.28
Data from the consultation and spirometry investiga-
tion were entered by the municipality into a password-
protected electronic database held by the Danish Technical 
University. The data recorded were age, gender, height, 
weight, smoking (status, history, and cessation), respiratory 
symptoms, and Medical Research Council (MRC) dyspnea 
scale for grading the degree of a patient’s breathlessness 
relating to daily   activities.29 FEV1 and FVC results given by 
  spirometry were also entered into the database. The   database 
calculated whether the person had evidence of airway 
obstruction and estimated the severity of COPD based on 
screening spirometry.
The data were analyzed using SPSS version 19.0 (SPSS 
Inc, Chicago, IL). Checking normal plots and Q-Q plots for 
normally distributed data descriptive statistics were presented 
as the mean ± standard deviation. For comparisons between 
subjects with evidence of airflow obstruction and those 
without, between men and women, and between smokers 
and nonsmokers, the Chi-square test and t-test were used 
depending on the data analyzed and the scale level of these 
data. Furthermore, correlation testing using the Chi-square 
test or the t-test was performed between specific variables, 
such as respiratory symptoms and MRC dyspnea scale. 
A significance level of 5% was chosen.
All citizens participating in the study provided their 
informed consent. The Danish Data Protection Agency was 
notified about the study, because it was covered by a general 
approval to perform noninterventional studies. The study 
protocol was also submitted to the local ethics committee 
and the Danish Medicines Agency for approval. However, 
being a noninterventional study, both authorities judged that 
the study did not require their approval.
Results
In total, 152 citizens in the Municipality of Esbjerg met 
the inclusion criteria (Table 1). Of the participants, 51% 
were active smokers smoking 16 cigarettes per day. All 
participants reported at least one respiratory symptom, with 
an average of 2.4 ± 1.17 symptoms per participant (data not 
shown). Dyspnea (70%), cough (65%), and sputum (48%) 
were the most frequent symptoms reported, whereas fewer 
subjects reported wheezing (36%) or a tendency to contract 
pneumonia (21%). The MRC dyspnea scale showed an 
Table 1 Demographics and characteristics of 152 citizens
Females  
(n = 76)  
Mean ± SD
Males  
(n = 76)  
Mean ± SD
Age (years) 57 ± 11.83 60 ± 10.86
Body mass index (kg/m2)a 25 ± 4.87 27 ± 4.22
Current/former smokers (%) 55/45 47/53
Pack-years of smokingb 24 ± 14.25c 38 ± 22.02
Average number of cigarettes per dayd 15 ± 6.27 20 ± 11.40
Notes: aSignificant difference between women and men (t-test 4.02, P , 0.001); 
bsignificant difference between women and men (t-test 3.57, P = 0.001); cinformation 
is missing for two persons; dcurrent smokers.
Abbreviation: SD, standard deviation.
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average score of 1.6 ± 0.83, with a daily level of activity 
between “not troubled by breathlessness except on strenuous 
exercise” and “short of breath when hurrying or walking up 
a slight hill”. However, some subjects had MRC scales up 
to severe levels of 3–5, and the level on the MRC scale was 
correlated with increasing number of respiratory symptoms 
(Chi-square 69.5, P , 0.001).
Spirometry examinations
Table 2 shows the results of screening spirometry. The 
average FEV1/FVC ratio was slightly below the defini-
tion of airway obstruction (68.8 ± 10.42). In our sample of 
152 subjects, 78 (51.3%) had evidence of airway obstruction, 
although the final diagnosis was made by their general prac-
titioner (Figure 1). This was the case for significantly more 
men (60%) than women (42%) at the municipality screening 
(Chi-square 5.2, P = 0.02). In addition to these 78 citizens 
with evidence of airway obstruction, a further 14 participants 
had evidence of restrictive lung disease. These two groups 
(61%) were advised by the municipality to visit their general 
practitioner for further diagnosis and intervention. Fourteen 
percent of the 78 citizens with evidence of airway obstruction 
were assessed to have severe to very severe COPD, whereas 
the rest were mild to moderate (Figure 1).
Diagnosis of COPD in general practice
Telephone interviews after 3 months (92% response rate,12 lost 
to follow-up) revealed that seven of 10 citizens advised to 
visit their general practitioner for a diagnosis did so. Among 
the citizens visiting their general practitioner with evidence 
of airway obstruction from the municipality screening, 85% 
were diagnosed by the general practitioner as having COPD 
(40 of 47 citizens). Those screened and found to have evidence 
of moderate (24/25) to very severe (nine citizens with severe 
to very severe) airway obstruction were also subsequently 
diagnosed to have COPD by their general practitioner. The 
uncertainty in municipality screening was related to subjects 
with mild airway obstruction (46% disagreement, seven 
of 13 citizens were diagnosed with COPD). Participants 
not visiting their general practitioner were more frequently 
women, smokers, were smoking significantly fewer cigarettes 
per day (having a significantly lower score on the MRC dys-
pnea scale), and had fewer respiratory symptoms, as well as 
evidence of airway obstruction which was mild or moderate 
in severity. However, for most characteristics, the differences 
between those citizens visiting their general practitioner and 
those who did not were not statistically significant. The mean 
age and average FEV1/FVC ratio were also not found to be 
different between the two groups.
Treatment initiated for COPD patients
According to GOLD guidelines, the primary strategy is to 
reduce the risk factors for COPD, in particular smoking.1 The 
follow-up telephone interview at 3 months after screening 
found significantly fewer smokers than at the time of screen-
ing (self-assessment, point prevalence) among those with 
an indication of airway obstruction (40% fewer smokers, 
Chi-square 24.6, P , 0.001). Participants who continued to 
smoke after 3 months had a significantly lower FEV1/FVC 
ratio (t-test 2.2; P = 0.03), and their airway obstruction were 
significantly less severe than those quitting smoking (Chi-
square 15.6, P = 0.08). Furthermore, 57% of those diagnosed 
with COPD were undergoing smoking cessation at follow-up 
compared with only 8% at the time of screening. The study 
also identified fewer smokers among those without evidence 
of airway obstruction (15% fewer smokers, Chi-square 49.6, 
P , 0.001). Regarding management of stable COPD, 61% 
of participants with a diagnosis of COPD had medication 
prescribed by their GP. Finally, 16% of the patients diagnosed 
to have COPD were referred subsequently by their GP to 
the municipality rehabilitation program. The lower figure 
for patients undergoing rehabilitation could reflect the short 
time period of follow-up, as well as the general practitioner’s 
ability to offer this in their practice.
Table 2 Results of spirometry examination for 152 citizens
Mean SD
FEV1 (per liter) 2.43 0.79
FVC (per liter) 3.53 1.03
FEV1/FVC ratio 68.76 10.42
Expected FEV1 3.06 0.67
FEV1 % of expected 79.36 18.33
Abbreviations: SD, standard deviation; FEV1, forced expiratory volume in one 
second; FVC, forced vital capacity.
No indication of
airway obstruction
FEV1/FVC > 70%
48.87% (74)
Indication of
airway obstruction
FEV1/FVC < 70%
51.3% (78)
Mild 32% (24)
Moderate 55% (42)
Severe 10% (8)
Very severe 3% (2)
Figure  1  Airway  obstruction  and  indicated  severity  of  chronic  obstructive 
pulmonary disease based on screening spirometry in 152 citizens. Absolute numbers 
in brackets. Information on severity of disease was missing for two citizens.
Abbreviations: FEV1, forced expiratory volume in one second; FVC, forced vital 
capacity.
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Discussion
This study investigated whether early detection of airway 
obstruction among citizens in the population at risk is fea-
sible and effective at the municipality level in Denmark. The 
results showed that 50% of the citizens studied have indica-
tions of airway obstruction with most of them (85%) ending 
up with a final diagnosis of COPD, indicating that early detec-
tion of COPD in the municipalities is feasible, worthwhile, 
and effective. Only 1–2 of every ten citizens screened with 
evidence of airway obstruction were false-positive, and these 
false positives were nearly all suspected to have mild airway 
obstruction. Furthermore, the number of smokers quitting, 
as well as the frequency of smoking cessation, was increased 
3 months after screening for airway obstruction. 
This was also the case for a smaller proportion of citizens 
with no evidence of airway obstruction (15%), which con-
firms the importance of awareness at the time of screening 
concerning smoking and the risk of having COPD. These 
results are in accordance with the COPD guidelines recom-
mending smoking cessation as the primary intervention.1
General practice is an important arena for early detec-
tion of COPD. The participants could have visited their GP. 
However, they did not do so. Municipality screening made 
the risk factors for COPD and the possibility of examina-
tion visible to citizens; it was more anonymous and non-
committed compared with visiting their own general 
practitioner. The reasons why a small proportion of subjects 
did not visit their general practitioner after municipality 
screening included being unaware of the need for further 
diagnosis by the general practitioner, having not had the 
time to do so yet, taking the initiative to quit smoking by 
themselves, and sensing a lack of interest by their general 
practitioner concerning COPD and smoking cessation. In 
addition to the minority of participants not understanding 
the seriousness of the screening result and need for further 
action, the municipalities are an important ancillary arena 
for early detection of COPD that attracts additional persons 
at risk of having COPD. This is in accordance with the 
recommendation made by the governmental prevention 
commission.25
As already mentioned, the different guidelines and rec-
ommendations do not recommend spirometric screening of 
adults for COPD in the community.1,16,17 On the other hand, 
reviews of spirometry show its importance.19 Although 
performed on a small scale, the present study has shown 
that spirometric screening in the community is feasible and 
effective. Despite some of the recommendations against 
screening with spirometry, eg, from the US Preventive 
Services Task Force,16 community screening in the present 
study focused on a population at risk who had recognized 
respiratory symptoms and were smokers or former smokers, 
and therefore not healthy or asymptomatic adults. This fol-
lows the official Danish guidelines issued by the National 
Board of Health.3
The finding that more than 50% of subjects had evidence 
of airway obstruction in the present study is higher than 
rates reported by other researchers.20–24 One major reason 
for this is probably the self-referral method used for recruit-
ment in the present study, with newspaper advertisements 
showing the risk group indicators for COPD according to 
the Danish National Board of Health. Many of the citizens 
visiting the Healthcare Center for examination may have 
been aware that they were likely to have lung disease. 
However, they were still not diagnosed with COPD before 
the visit and therefore screening was relevant to them. 
Second, the possibility of remaining anonymous during 
spirometric screening when undertaken in the municipal-
ity may have been another   explanation. Finally, it has to be 
remembered that the proportion of subjects ending up with 
a diagnosis of COPD after visiting their general practitioner 
was lower (44%).
Study limitations
The present study had some limitations. First, the sample 
size was small. However, this was a pilot study to investigate 
the feasibility and potential success of screening for airway 
obstruction at the community level. Second, recruitment for 
screening was based upon self-referral, with a risk of selec-
tion bias towards those with the disease of interest. However, 
those identified were undiagnosed beforehand and at risk of 
suffering from COPD, which is why screening was deemed 
relevant, and investigating prevalence was not part of the aim 
of this study. Third, the data on diagnosis and treatment in 
general practice were patient-reported and not information 
supplied directly by general practitioners. Patient-reporting 
may have limitations in terms of recall bias and uncertainty, 
but was considered to be the only feasible way to obtain the 
data. Fourth, guidelines suggest that the final diagnosis in 
general practice should include reversibility testing with 
bronchodilators and repeat spirometry.1 We have to assume 
that this was the case in general practice, but because this 
was not recorded, there is some uncertainty. However, new 
data have been reported using the same inclusion criteria 
for screening in primary care in Denmark as in the pres-
ent study, but with repeated reversibility testing.30 Of 4049 
screened patients, 23.1% had airway obstruction, with 21.7% 
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confirmed to have COPD after reversibility testing.30 These 
data indicate that only a small number of patients initially 
identified using spirometry alone do not have COPD after 
reversibility testing. Furthermore, Danish guidelines from the 
National Board of Health only recommend use of spirometry 
for the early detection of COPD.3 Fifth, the current interna-
tional guidelines question the use of fixed ratios and FEV1/
FVC, resulting in misclassification.1,16 However, due to the 
noninterventional nature of this study, the current Danish 
guidelines as to classification had to be followed in the present 
study.3,27 It is expected that these national guidelines will be 
updated to reflect the new 2011 GOLD update.
Conclusion
Together with early detection of COPD in general practice, 
early detection of airway obstruction in defined risk popula-
tions in Danish municipalities seems feasible and effective 
in identifying new undetected COPD patients. The results of 
the present study provide some indication of the potential of 
using spirometry at the municipality level for early detection 
of COPD. On the other hand, the results of the study cannot 
be used to support community screening of COPD in healthy 
and/or asymptomatic adults, as argued against by US Preven-
tive Services Task Force.16
Our results could be of interest to other countries, given 
the feasibility and potential shown with community screen-
ing of a population at risk. The potential in other countries 
will of course depend upon the eventual guidelines for 
early detection of COPD, as well as the expected propor-
tion of undiagnosed COPD patients in the country, which is 
regarded as rather high in Denmark.2,3 Additional research 
is needed in larger samples of people at risk of COPD and 
in more municipalities to see whether the successful results 
found for community screening in the present study can be 
confirmed. This research could also include investigation of 
whether early intervention improves morbidity and mortal-
ity and saves costs for the municipality, health care sector, 
and society.
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